|
NDUFB3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.830200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.145800E-01 |
| Normal-vs-Stage2 |
6.164600E-01 |
| Normal-vs-Stage3 |
1.109990E-02 |
| Normal-vs-Stage4 |
6.977400E-01 |
| Stage1-vs-Stage2 |
9.661800E-01 |
| Stage1-vs-Stage3 |
3.359800E-02 |
| Stage1-vs-Stage4 |
9.945400E-01 |
| Stage2-vs-Stage3 |
9.370100E-02 |
| Stage2-vs-Stage4 |
9.809400E-01 |
| Stage3-vs-Stage4 |
1.645830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.370000E-01 |
| Normal-vs-AfricanAmerican |
9.800000E-01 |
| Normal-vs-Asian |
8.430000E-01 |
| Caucasian-vs-AfricanAmerican |
5.005600E-01 |
| Caucasian-vs-Asian |
6.924400E-01 |
| AfricanAmerican-vs-Asian |
8.857200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.268400E-01 |
| Normal-vs-Female |
9.452800E-01 |
| Male-vs-Female |
2.885200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.702000E-01 |
| Normal-vs-Extreme_Weight |
5.450000E-01 |
| Normal-vs-Obese |
4.160400E-01 |
| Normal-vs-Extreme_Obese |
3.234000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.131200E-01 |
| Normal_Weight-vs-Obese |
8.814400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.140200E-01 |
| Extreme_Weight-vs-Obese |
7.190000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.335000E-01 |
| Obese-vs-Extreme_Obese |
1.528150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.213400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.730800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.210200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.353200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.012200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.332400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.277000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.857400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.157600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.494200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.721000E-01 |
| Normal-VS-Type2 PRCC |
3.329600E-01 |
| Normal-VS-KIRP CIMP |
2.018400E-03 |
| Normal-VS-Unclassified PRCC |
2.806800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.175000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.623300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.869600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.081400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.386400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.142300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.404000E-01 |
| Normal-vs-N1 |
6.638300E-02 |
| Normal-vs-N2 |
6.395200E-01 |
| N0-vs-N1 |
3.409800E-01 |
| N0-vs-N2 |
4.528800E-01 |
| N1-vs-N2 |
2.677200E-01 |
|
|
